Nuevocor is a new biotech start-up in Singapore striving to develop gene therapies for genetic cardiomyopathies. It will leverage a deep understanding of cardiac cell biology, as well as a technology platform encompassing novel gene therapy vectors and proteomics-based target discovery
Employees: 11-50
Total raised: $69M
Founded date: 2020
Investors 2
| Date | Name | Website |
| - | EVX Ventur... | evx.ventur... |
| - | SEEDS Capi... | seedscapit... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.05.2025 | Series B | $45M | - |
| 18.06.2021 | Series A | $24M | - |
Mentions in press and media 21
| Date | Title | Description |
| 07.07.2025 | Nuevocor Strengthens Board with Appointment of Thierry Abribat | SINGAPORE, July 7, 2025 /PRNewswire/ -- Nuevocor, a Singapore-headquartered biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, today announced the appointment of Dr. Thierry Abribat to its Board o... |
| 10.06.2025 | Nuevocor Announces FDA Clearance of IND for NVC-001 for LMNA-Related Dilated Cardiomyopathy | LMNA-related dilated cardiomyopathy (LMNA DCM) is one of the most aggressive forms of DCM, affecting approximately 100,000 individuals in the United States and Europe, who progress rapidly to end-stage heart failure. NVC-001 demonstrated si... |
| 28.05.2025 | To develop novel therapies for cardiomyopathy, Nuevocor raised $45 M Series B funding | The Singapore-based IND-stage biotechnology startup Nuevocor, which is working to find treatments for cardiomyopathies caused by aberrant mechanobiology, has successfully closed a $45 million Series B funding round. Nuevocor said in a state... |
| 08.05.2025 | Nuevocor: $45 Million Series B Raised For Clinical Development Of Novel Mechanobiology-Centered Therapy For Cardiomyopathy | Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, announced the completion of a $45 million Series B financing. Kurma Partners and Angelini Ventures ... |
| 08.05.2025 | Deals in brief: Wavemaker Impact leads Arysun’s pre-seed round, Nuevocor raises USD 45 million, latest funding deals in China, and more | Arysun lands USD 575,000 to accelerate solar adoption in Southeast Asia Arysun, a Singapore-based climate tech startup, has secured USD 575,000 in pre-seed funding to broaden access to rooftop solar solutions for Southeast Asian households.... |
| 07.05.2025 | Nuevocor's $45 Million Leap: A New Dawn for Cardiomyopathy Treatment | In the world of biotechnology, every dollar counts. A recent infusion of $45 million into Nuevocor, a Singapore-based company, is more than just a financial boost. It’s a lifeline for patients grappling with cardiomyopathies, particularly t... |
| 06.05.2025 | Nuevocor Closes US$45M Series B Financing | Nuevocor, a Singapore-based IND-stage biotechnology company developing cures for cardiomyopathies, raised US$45M in Series B funding. The round was led by Kurma Partners and Angelini Ventures, with participation from existing investors EDBI... |
| 06.05.2025 | Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy | – Round co-led by new investors, Kurma Partners and Angelini Ventures, with significant participation from existing investors EDBI, ClavystBio, and Boehringer Ingelheim Venture Fund – Proceeds will support the Phase 1/2 clinical trial of le... |
| 06.05.2025 | SG biotech startup Nuevocor raises $45m to help heart failure patients | Singapore-based biotech company Nuevocor has raised $45 million in a Series B funding round to advance the treatment for patients with cardiomyopathies, a form of heart disease that could lead to heart failure, according to a statement on T... |
| 25.01.2025 | Andhra Pradesh's Bold Bid for Swiss Investment: A New Economic Horizon | Andhra Pradesh is casting its net wide. The state is on a mission to attract Swiss investments in research and development (R&D) and manufacturing. This is not just a call for funds; it’s a strategic move to reshape its economic landsca... |
Show more